Welcome to our dedicated page for AUNA S.A. SEC filings (Ticker: AUNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Auna S.A. (NYSE: AUNA) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. Auna files an annual report on Form 20-F and furnishes current information on Form 6-K, which together document its activities as a Latin American healthcare platform operating in Mexico, Peru, and Colombia. These filings include press releases on financial results, financing transactions, and operational milestones, as well as management’s discussion and analysis of financial condition and results of operations for specified periods.
Recent Form 6-K submissions reference quarterly financial results, including unaudited condensed consolidated interim financial statements, and discuss performance across Auna’s healthcare facilities and health plan portfolio. Other 6-K filings relate to proposed and completed offerings of senior secured notes, a significant debt refinancing, and cash tender offers and consent solicitations for outstanding notes. Through these documents, readers can follow how Auna describes its leverage ratios, debt maturity profile, and capital structure objectives.
Auna’s filings also incorporate disclosures on strategic initiatives. Examples include the expansion of its OncoMexico network through partnerships with medical institutions, a public–private partnership with EsSalud in Peru for the Torre Trecca outpatient treatment center, and a Memorandum of Understanding with Sojitz Corporation of America to explore healthcare opportunities in Latin America. These items appear in press releases that are furnished to the SEC as exhibits to Form 6-K reports.
On Stock Titan, users can review Auna’s 20-F and 6-K filings as they become available from EDGAR and use AI-powered summaries to interpret key points. This includes simplified explanations of annual and interim financial reporting, context around debt and note offerings, and highlights from operational and strategic disclosures, all based on the information Auna provides in its official filings.
Auna S.A., a Latin American healthcare company operating in Mexico, Peru and Colombia, has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the SEC.
The report is available on both the SEC’s website and Auna’s investor relations site, and shareholders can request hard copies of the audited financial statements free of charge. As of March 31, 2026, Auna’s network comprised 31 healthcare facilities with 2,333 beds and 1.4 million health plan members.
AUNA, S.A. reported a Schedule 13G/A amendment showing RWC Asset Management LLP beneficially owns 1,520,929 shares, equal to 5.05% of the class. The filing states RWC has sole voting and sole dispositive power over the 1,520,929 shares. The amendment is signed by Mr. Fadi Freiha as Compliance Officer.
Auna S.A., a Luxembourg-based healthcare group operating hospitals and prepaid health plans in Mexico, Peru and Colombia, has filed its Form 20-F annual report prepared under IFRS Accounting Standards, including audited consolidated financial statements for the years ended December 31, 2025, 2024 and 2023.
The report explains extensive use of non-GAAP metrics such as EBITDA, Adjusted EBITDA, Adjusted Net Income and Adjusted Leverage Ratio, alongside medical loss ratio to assess performance, especially in healthcare coverage. It highlights reliance on third-party payers and government-linked insurers, long collection cycles—up to 165 days in Colombia—and competition from both private and public providers.
Auna reports positive working capital of S/177.5 million (US$52.8 million) as of December 31, 2025, but flags significant risks: pressure on reimbursement schemes in Colombia, ongoing large IT and ERP implementations with prior migration issues, intense competition for medical talent and brands, and identified material weaknesses in internal control over financial reporting.
Auna S.A. reported preliminary operating metrics for the first quarter ended March 31, 2026 across its healthcare platforms in Mexico, Peru and Colombia. The data cover emergency treatments, surgeries, days hospitalized, capacity utilization and oncology sessions, plus memberships and protected lives.
In Mexico, 1Q26 emergency treatments were 7,864 thousand and chemotherapies and radiotherapies reached 4,162 sessions. In Peru, total capacity utilization was 76.3% and chemotherapies and radiotherapies totaled 12,718 sessions. In Colombia, capacity utilization was 79.3% and protected lives under risk-sharing agreements were 3,057,763 in 1Q26.
As of March 31, 2026, Auna’s network comprised 31 healthcare facilities with 2,333 beds and 1.4 million health plan members, underscoring its position as a large integrated healthcare platform in Latin America. All figures are preliminary and may change when final first-quarter indicators are released.
AUNA S.A. director and president Jesus Zamora reports his initial ownership position in the company’s shares and options. He holds performance share options over 2,217,528 Class A common shares at an exercise price of $12.00 per share, expiring on March 21, 2034. He also holds performance share options over 277,778 Class A shares and share options over 209,677 Class A shares, each with a $6.32 exercise price and expiring on July 11, 2035. In addition, he directly owns 30,710 Class A common shares and indirectly owns 32,029,016 Class B common shares through Enfoca entities, with each Class B share convertible into one Class A share. The performance options vest only if AUNA’s Class A share price meets specified targets of $12.00, $21.00, $30.00 or $9.48, while one share option grant vests in four equal annual installments beginning on July 11, 2026.
AUNA S.A. director Luis Felipe Pinillos Casabonne filed an amended ownership report to add a previously omitted performance share option. The option covers 443,505 underlying Class A common shares at an exercise price of $12.00 per share and expires on March 21, 2029. It will conditionally vest in three equal tranches if the share price reaches $12.00, $21.00 and $30.00 per share, respectively. This amendment reflects holdings; it does not report a new purchase or sale.
AUNA S.A. officer Vicente Checa, Gerente General Peru, filed an initial ownership report showing 4,706 Class A Common Shares, including 3,706 shares underlying restricted share units. He also holds options over 20,000 shares at $12.00 expiring in 2029 and 32,500 shares at $6.32 expiring in 2035, each vesting in four annual installments from March 21, 2025 and July 11, 2026, respectively.
AUNA S.A. filed an initial ownership report for director Guadalupe Phillips on Form 3. The filing identifies Phillips as a director of AUNA S.A. and, in this excerpt, does not list any share purchase, sale, or derivative transactions.
AUNA S.A. executive Alejandro Torres Martinez, identified as an officer with the title "Director General Mexico," submitted an initial insider ownership report on Form 3. The filing lists his role at the company but does not report any specific share transactions or holdings in this excerpt.
AUNA S.A. director Wilton John filed an initial ownership report showing his stake in the company. The Form 3 indicates he beneficially owns 67,548 Class A common shares directly. This amount includes 21,299 common shares underlying outstanding restricted share units, reflecting both current shares and equity-based compensation awards.